| Class information for:  | 
| Basic class information | 
| ID | Publications | Average number of references | Avg. shr. active ref. in WoS | 
|---|---|---|---|
| 17736 | 521 | 23.8 | 60% | 
| Classes in level above (level 2) | 
| ID, lev. above | Publications | Label for level above | 
|---|---|---|
| 708 | 12194 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE | 
| Terms with highest relevance score | 
| Rank | Term | Type of term | Relevance score (tfidf) | Class's shr. of term's tot. occurrences | Shr. of publ. in class containing term | Num. of publ. in class | 
|---|---|---|---|---|---|---|
| 1 | NORVERAPAMIL | Author keyword | 22 | 63% | 4% | 22 | 
| 2 | CLIN PHARMACOL GERIATR MED | Address | 4 | 75% | 1% | 3 | 
| 3 | S VERAPAMIL | Author keyword | 1 | 100% | 0% | 2 | 
| 4 | VERAPAMIL METABOLITES | Author keyword | 1 | 100% | 0% | 2 | 
| 5 | CAS 52 53 9 | Author keyword | 1 | 30% | 1% | 3 | 
| 6 | CHIRAL ASSAY | Author keyword | 1 | 40% | 0% | 2 | 
| 7 | CONCENTRATION EFFECT ANALYSIS | Author keyword | 1 | 40% | 0% | 2 | 
| 8 | VERAPAMIL HYDROCHLORIDE | Author keyword | 1 | 13% | 1% | 7 | 
| 9 | ACUTE AND CHRONIC EFFECT | Author keyword | 1 | 50% | 0% | 1 | 
| 10 | CHLOROMINE T | Author keyword | 1 | 50% | 0% | 1 | 
| Web of Science journal categories | 
| Author Key Words | 
| Rank | Web of Science journal category | Relevance score (tfidf) | Class's shr. of term's tot. occurrences | Shr. of publ. in class containing term | Num. of publ. in class | LCSH search | Wikipedia search | 
|---|---|---|---|---|---|---|---|
| 1 | NORVERAPAMIL | 22 | 63% | 4% | 22 | Search NORVERAPAMIL | Search NORVERAPAMIL | 
| 2 | S VERAPAMIL | 1 | 100% | 0% | 2 | Search S+VERAPAMIL | Search S+VERAPAMIL | 
| 3 | VERAPAMIL METABOLITES | 1 | 100% | 0% | 2 | Search VERAPAMIL+METABOLITES | Search VERAPAMIL+METABOLITES | 
| 4 | CAS 52 53 9 | 1 | 30% | 1% | 3 | Search CAS+52+53+9 | Search CAS+52+53+9 | 
| 5 | CHIRAL ASSAY | 1 | 40% | 0% | 2 | Search CHIRAL+ASSAY | Search CHIRAL+ASSAY | 
| 6 | CONCENTRATION EFFECT ANALYSIS | 1 | 40% | 0% | 2 | Search CONCENTRATION+EFFECT+ANALYSIS | Search CONCENTRATION+EFFECT+ANALYSIS | 
| 7 | VERAPAMIL HYDROCHLORIDE | 1 | 13% | 1% | 7 | Search VERAPAMIL+HYDROCHLORIDE | Search VERAPAMIL+HYDROCHLORIDE | 
| 8 | ACUTE AND CHRONIC EFFECT | 1 | 50% | 0% | 1 | Search ACUTE+AND+CHRONIC+EFFECT | Search ACUTE+AND+CHRONIC+EFFECT | 
| 9 | CHLOROMINE T | 1 | 50% | 0% | 1 | Search CHLOROMINE+T | Search CHLOROMINE+T | 
| 10 | FLUORIMETRIC DETECTOR | 1 | 50% | 0% | 1 | Search FLUORIMETRIC+DETECTOR | Search FLUORIMETRIC+DETECTOR | 
| Key Words Plus | 
| Rank | Web of Science journal category | Relevance score (tfidf) | Class's shr. of term's tot. occurrences | Shr. of publ. in class containing term | Num. of publ. in class | 
|---|---|---|---|---|---|
| 1 | NORVERAPAMIL | 61 | 71% | 9% | 49 | 
| 2 | HIGHLY CLEARED DRUGS | 31 | 92% | 2% | 12 | 
| 3 | DEXTRO VERAPAMIL | 24 | 82% | 3% | 14 | 
| 4 | STEREOSELECTIVE 1ST PASS METABOLISM | 17 | 59% | 4% | 19 | 
| 5 | NORVERAPAMIL ENANTIOMERS | 8 | 75% | 1% | 6 | 
| 6 | FIRST PASS ELIMINATION | 6 | 80% | 1% | 4 | 
| 7 | RACEMIC VERAPAMIL | 6 | 53% | 2% | 8 | 
| 8 | NORGALLOPAMIL | 3 | 100% | 1% | 3 | 
| 9 | STABLE ISOTOPE TECHNIQUE | 2 | 44% | 1% | 4 | 
| 10 | VERAPAMIL ENANTIOMERS | 2 | 43% | 1% | 3 | 
| Journals | 
| Reviews | 
| Title | Publ. year | Cit. | Active references | % act. ref. to same field | 
|---|---|---|---|---|
| VERAPAMIL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION | 1989 | 139 | 277 | 30% | 
| CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM | 1986 | 156 | 117 | 31% | 
| A Fast and Simple Conductometric Method for Verapamil Hydrochloride Determination in Pharmaceutical Formulations | 2011 | 3 | 17 | 35% | 
| CLINICAL PHARMACOKINETICS OF VERAPAMIL | 1984 | 96 | 49 | 55% | 
| Is Antiarrhythmic Treatment in the Elderly Different? A Review of the Specific Changes | 2011 | 7 | 71 | 10% | 
| Stereoselectivity of drug action | 1997 | 32 | 57 | 14% | 
| CALCIUM-ANTAGONISTS IN CARDIOLOGY - UPDATE ON SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS | 1991 | 5 | 12 | 42% | 
| CONCENTRATION-EFFECT ANALYSIS OF ANTIHYPERTENSIVE DRUG RESPONSE - FOCUS ON CALCIUM-ANTAGONISTS | 1994 | 10 | 37 | 19% | 
| DEVELOPING STEREOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAYS FOR PHARMACOKINETIC STUDIES | 1992 | 1 | 6 | 33% | 
| HYPERBARIC-OXYGEN AND ANTIANGINAL AGENTS - EXPERIMENTAL AND CLINICAL ASPECTS OF THEIR INTERACTION | 1990 | 0 | 10 | 40% | 
| Address terms | 
| Rank | Address term | Relevance score (tfidf) | Class's shr. of term's tot. occurrences | Shr. of publ. in class containing term | Num. of publ. in class | 
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOL GERIATR MED | 4 | 75% | 0.6% | 3 | 
| 2 | SECT DRUG ANAL | 1 | 50% | 0.2% | 1 | 
| 3 | FRAUNHOFER TOXICOL AEROSOL | 0 | 33% | 0.2% | 1 | 
| 4 | KIMIA IDEA PARDAZ AZARBAYJAN SCI BASED CO | 0 | 33% | 0.2% | 1 | 
| 5 | AREA QUIM ANALITICA | 0 | 25% | 0.2% | 1 | 
| 6 | JEWISH HOME SAN FRANCISCO | 0 | 20% | 0.2% | 1 | 
| 7 | BIOCHEM PHARMACOL BIOTOXICOL | 0 | 13% | 0.2% | 1 | 
| 8 | ANALYT TOXICOL THER EUT DRUG MONITORING | 0 | 11% | 0.2% | 1 | 
| 9 | ELE OCHEM SENSORS | 0 | 10% | 0.2% | 1 | 
| 10 | OSPED MAGGIORE FISIOL CLIN IPERTENS | 0 | 100% | 0.2% | 1 | 
| Related classes at same level (level 1) | 
| Rank | Relatedness score | Related classes | 
|---|---|---|
| 1 | 0.0000215067 | ELGODIPINE//NISOLDIPINE//GALLOPAMIL | 
| 2 | 0.0000183883 | HIGH DOSE INSULIN//CALCIUM CHANNEL BLOCKER OVERDOSE//VERAPAMIL TOXICITY | 
| 3 | 0.0000169382 | DESACETYLDILTIAZEM//DEACETYLDILTIAZEM//CAS 42399 41 7 | 
| 4 | 0.0000139769 | MEBUDIPINE//BARNIDIPINE HYDROCHLORIDE//BARNIDIPINE | 
| 5 | 0.0000139314 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION | 
| 6 | 0.0000130950 | DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER//ETAFTORON//HOSP XIAMEN AFFILIATED 1 | 
| 7 | 0.0000096555 | MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM | 
| 8 | 0.0000081534 | FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE | 
| 9 | 0.0000064844 | DIBROMANTIN//1 3 DIBROMO 5 5 DIMETHYL 2 4 IMIDAZOLIDINEDIONE 77 48 5//BETA KETO CARBONYL COMPOUNDS | 
| 10 | 0.0000061333 | PHARMACOL RE6640//SPP301//AVOSENTAN |